Literature DB >> 26810939

Outcomes after resection of cortisol-secreting adrenocortical carcinoma.

Georgios Antonios Margonis1, Yuhree Kim1, Thuy B Tran2, Lauren M Postlewait3, Shishir K Maithel3, Tracy S Wang4, Jason A Glenn4, Ioannis Hatzaras5, Rivfka Shenoy5, John E Phay6, Kara Keplinger6, Ryan C Fields7, Linda X Jin7, Sharon M Weber8, Ahmed Salem8, Jason K Sicklick9, Shady Gad9, Adam C Yopp10, John C Mansour10, Quan-Yang Duh11, Natalie Seiser11, Carmen C Solorzano12, Colleen M Kiernan12, Konstantinos I Votanopoulos13, Edward A Levine13, George A Poultsides2, Timothy M Pawlik14.   

Abstract

BACKGROUND: We sought to define the impact of cortisol-secreting status on outcomes after surgical resection of adrenocortical carcinoma (ACC).
METHODS: The U.S ACC group database was queried to identify patients who underwent ACC resection between 1993 and 2014. The short-term and long-term outcomes were assessed.
RESULTS: The incidence of all functional and cortisol-secreting tumors was 40.6% and 22.6%, respectively. On multivariable analysis, cortisol secretion remained associated with an increased risk of postoperative complications (odds ratio = 2.25, 95 % confidence interval = 1.04 to 4.88; P = .04). At a median follow-up of 17.6 months, 118 patients (50.4%) had developed a recurrence. On multivariable analysis, after adjusting for patient and disease-related factors cortisol secretion independently predicted shorter recurrence-free survival (Hazard ratio = 2.05, 95% confidence interval = 1.16 to 3.60; P = .01).
CONCLUSIONS: Cortisol secretion was associated with an increased risk of postoperative morbidity. Recurrence remains high among patients with ACC after surgery; cortisol secretion was independently associated with a shorter recurrence-free survival. Tailoring postoperative surveillance of ACC patients based on their cortisol secreting status may be important.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adrenocortical; Carcinoma; Cortisol; Outcomes

Mesh:

Substances:

Year:  2015        PMID: 26810939      PMCID: PMC4957943          DOI: 10.1016/j.amjsurg.2015.09.020

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  30 in total

Review 1.  Adrenocortical carcinoma: past, present, and future.

Authors:  Jennifer Lafemina; Murray F Brennan
Journal:  J Surg Oncol       Date:  2012-04-03       Impact factor: 3.454

Review 2.  Aldosterone-producing adrenocortical carcinoma: an unusual cause of Conn's syndrome with an ominous clinical course.

Authors:  Teresa M Seccia; Ambrogio Fassina; Gastone G Nussdorfer; Achille C Pessina; Gian Paolo Rossi
Journal:  Endocr Relat Cancer       Date:  2005-03       Impact factor: 5.678

Review 3.  Surgical management of adrenocortical carcinoma.

Authors:  Gustavo G Fernandez Ranvier; William B Inabnet
Journal:  Endocrinol Metab Clin North Am       Date:  2015-03-17       Impact factor: 4.741

Review 4.  Management of patients with adrenal cancer: recommendations of an international consensus conference.

Authors:  D E Schteingart; G M Doherty; P G Gauger; T J Giordano; G D Hammer; M Korobkin; F P Worden
Journal:  Endocr Relat Cancer       Date:  2005-09       Impact factor: 5.678

5.  Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients.

Authors:  Gwenaelle Abiven; Joel Coste; Lionel Groussin; Philippe Anract; Frédérique Tissier; Paul Legmann; Bertrand Dousset; Xavier Bertagna; Jérôme Bertherat
Journal:  J Clin Endocrinol Metab       Date:  2006-05-02       Impact factor: 5.958

6.  Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines.

Authors:  Susan K Lutgendorf; Steven Cole; Erin Costanzo; Sarah Bradley; Jeremy Coffin; Sarvenaz Jabbari; Kaitlin Rainwater; Justine M Ritchie; Maria Yang; Anil K Sood
Journal:  Clin Cancer Res       Date:  2003-10-01       Impact factor: 12.531

Review 7.  Adrenocortical cancer: pathophysiology and clinical management.

Authors:  Rossella Libè; Amato Fratticci; Jérôme Bertherat
Journal:  Endocr Relat Cancer       Date:  2007-03       Impact factor: 5.678

8.  Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer.

Authors:  Alfredo Berruti; Martin Fassnacht; Harm Haak; Tobias Else; Eric Baudin; Paola Sperone; Matthias Kroiss; Thomas Kerkhofs; Andrew R Williams; Arianna Ardito; Sophie Leboulleux; Marco Volante; Timo Deutschbein; Richards Feelders; Cristina Ronchi; Salvatore Grisanti; Hans Gelderblom; Francesco Porpiglia; Mauro Papotti; Gary D Hammer; Bruno Allolio; Massimo Terzolo
Journal:  Eur Urol       Date:  2013-11-14       Impact factor: 20.096

9.  Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center.

Authors:  Montserrat Ayala-Ramirez; Sina Jasim; Lei Feng; Shamim Ejaz; Ferhat Deniz; Naifa Busaidy; Steven G Waguespack; Aung Naing; Kanishka Sircar; Christopher G Wood; Lance Pagliaro; Camilo Jimenez; Rena Vassilopoulou-Sellin; Mouhammed Amir Habra
Journal:  Eur J Endocrinol       Date:  2013-10-23       Impact factor: 6.664

10.  Survival and prognostic factors for adrenocortical carcinoma: a single institution experience.

Authors:  Zlatibor Loncar; Vladimir Djukic; Vladan Zivaljevic; Tatjana Pekmezovic; Aleksandar Diklic; Svetislav Tatic; Dusko Dundjerovic; Branislav Olujic; Nikola Slijepcevic; Ivan Paunovic
Journal:  BMC Urol       Date:  2015-05-27       Impact factor: 2.264

View more
  17 in total

1.  The impact of patient-, disease-, and treatment-related factors on survival in patients with adrenocortical carcinoma.

Authors:  Nahid Punjani; Roderick Clark; Jonathan Izawa; Joseph Chin; Stephen E Pautler; Nicholas Power
Journal:  Can Urol Assoc J       Date:  2017-12-22       Impact factor: 1.862

2.  Blood Transfusion and Survival for Resected Adrenocortical Carcinoma: A Study from the United States Adrenocortical Carcinoma Group.

Authors:  Caroline E Poorman; Lauren M Postlewait; Cecilia G Ethun; Thuy B Tran; Jason D Prescott; Timothy M Pawlik; Tracy S Wang; Jason Glenn; Ioannis Hatzaras; Rivfka Shenoy; John E Phay; Kara Keplinger; Ryan C Fields; Linda X Jin; Sharon M Weber; Ahmed Salem; Jason K Sicklick; Shady Gad; Adam C Yopp; John C Mansour; Quan-Yang Duh; Natalie Seiser; Carmen C Solorzano; Colleen M Kiernan; Konstantinos I Votanopoulos; Edward A Levine; Charles A Staley; George A Poultsides; Shishir K Maithel
Journal:  Am Surg       Date:  2017-07-01       Impact factor: 0.688

3.  Diabetes mellitus and hyperglycemia are associated with inferior oncologic outcomes in adrenocortical carcinoma.

Authors:  Sean M Wrenn; T K Pandian; Rajshri M Gartland; Zhi Ven Fong; Matthew A Nehs
Journal:  Langenbecks Arch Surg       Date:  2021-02-01       Impact factor: 3.445

4.  Cumulative GRAS Score as a Predictor of Survival After Resection for Adrenocortical Carcinoma: Analysis From the U.S. Adrenocortical Carcinoma Database.

Authors:  Jordan J Baechle; Paula Marincola Smith; Carmen C Solórzano; Thuy B Tran; Lauren M Postlewait; Shishir K Maithel; Jason Prescott; Timothy Pawlik; Tracy S Wang; Jason Glenn; Ioannis Hatzaras; Rivfka Shenoy; John E Phay; Lawrence A Shirley; Ryan C Fields; Linda Jin; Daniel E Abbott; Sean Ronnekleiv-Kelly; Jason K Sicklick; Adam Yopp; John Mansour; Quan-Yang Duh; Natalie Seiser; Konstantinos Votanopoulos; Edward A Levine; George Poultsides; Colleen M Kiernan
Journal:  Ann Surg Oncol       Date:  2021-02-14       Impact factor: 5.344

5.  The Utrecht Score: A novel histopathological scoring system to assess the prognosis of dogs with cortisol-secreting adrenocortical tumours.

Authors:  Karin Sanders; Koen Cirkel; Guy C M Grinwis; Erik Teske; Sebastiaan A van Nimwegen; Jan A Mol; Jan Willem Hesselink; Hans S Kooistra; Sara Galac
Journal:  Vet Comp Oncol       Date:  2019-04-07       Impact factor: 2.613

6.  microRNA-431 as a Chemosensitizer and Potentiator of Drug Activity in Adrenocortical Carcinoma.

Authors:  Grace T Y Kwok; Jing Ting Zhao; Anthony R Glover; Anthony J Gill; Roderick Clifton-Bligh; Bruce G Robinson; Julian C Y Ip; Stan B Sidhu
Journal:  Oncologist       Date:  2019-03-27

7.  Laparoscopic major hepatectomy for hepatocellular carcinoma in elderly patients: a multicentric propensity score‑based analysis.

Authors:  Antonella Delvecchio; Maria Conticchio; Francesca Ratti; Maximiliano Gelli; Ferdinando Massimiliano Anelli; Alexis Laurent; Giulio Cesare Vitali; Paolo Magistri; Giacomo Assirati; Emanuele Felli; Taiga Wakabayashi; Patrick Pessaux; Tullio Piardi; Fabrizio Di Benedetto; Nicola de'Angelis; Javier Briceño-Delgado; Rene Adam; Daniel Cherqui; Luca Aldrighetti; Riccardo Memeo
Journal:  Surg Endosc       Date:  2020-08-03       Impact factor: 4.584

Review 8.  Surgical approach to patients with hypercortisolism.

Authors:  Colleen M Kiernan; Carmen C Solórzano
Journal:  Gland Surg       Date:  2020-02

9.  Giant androgen-producing adrenocortical carcinoma with atrial flutter: A case report and review of the literature.

Authors:  Mircea-Florin Costache; Raluca-Elena Arhirii; Simona-Juliette Mogos; Corina Lupascu-Ursulescu; Cezara-Ioana Litcanu; Adi-Ionut Ciumanghel; Catalina Cucu; Cristina-Mihaela Ghiciuc; Antoniu-Octavian Petris; Nicolae Danila
Journal:  World J Clin Cases       Date:  2021-07-16       Impact factor: 1.337

Review 10.  Adrenocortical carcinoma: current state of the art, ongoing controversies, and future directions in diagnosis and treatment.

Authors:  Omair A Shariq; Travis J McKenzie
Journal:  Ther Adv Chronic Dis       Date:  2021-07-20       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.